Seth Lederman insider trades
Open-market stock purchases and sales by Seth Lederman, Chief Executive Officer at Tonix Pharmaceuticals Holding Corp, from SEC Form 4 filings since Feb 12, 2013.
Track record: 90% of 31 scored buys are up 5% or more since purchase, averaging +112%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 9, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought | $59K |
| Mar 31, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought | $63.1K |
| Mar 18, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought | $223K |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought (not open market) | — |
| Feb 24, 2026 | TNXP Tonix Pharmaceuticals Holding Corp | Bought (not open market) | — |
Companies traded
- TNXP Tonix Pharmaceuticals Holding Corp: 45 buys, last Jun 9, 2026